effect of Memoral on memory after TBI

Effect of Memoral on the memory dysfunction after mild traumatic brain injury , a randomize clinical trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130310012776N8

Enrollment

Registered

2022-02-11

Start date

2022-02-04

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Memory impairment after mild brain injury. Crushing injury of skull

Interventions

Intervention 1: Intervention group: memoral capsules are given to patients every 8 hours at 8 am, 2 pm and 12 pm for one month. Intervention 2: Control group: placebo are given to patients every 8 hou

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Cases should have mild traumatic brain injury cases should have memory dysfunction after MTBI age between 20 and 60 years at least six class of education

Exclusion criteria

Exclusion criteria: moderate or severe brain injury history of psychiatric or neurological disorders history of hematologic disorders Having previous history of trauma Having major psychiatric and neurologic disorders according to the self-report

Design outcomes

Primary

Measure	Time frame
Patient memory function. Timepoint: Intervals of one month and three months after starting the drug. Method of measurement: Based on the auditory-verbal learning test questionnaire (AVLT).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosseinali Khalili

Shiraz University of Medical Sciences

khalili_h@sums.ac.ir+98 71 3625 4206

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026